Showing 101 - 120 results of 464 for search '"Multiple Sclerosis"', query time: 0.10s Refine Results
  1. 101
  2. 102

    Sexual Satisfaction in Fully Ambulatory People with Multiple Sclerosis: Does Disability Matter? by Pawel Dobrakowski, Agnieszka Machowska-Majchrzak, Beata Labuz-Roszak, Ewa Niewiadomska, Krystyna Pierzchala

    Published 2020-01-01
    “…The subjects completed the Montgomery-Asberg Depression Scale (MADRS), the Coping Inventory for Stressful Situations (CISS), the Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-19), and the Sexual Satisfaction Questionnaire (SSQ). …”
    Get full text
    Article
  3. 103
  4. 104

    The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients by Andreea Romaniuc, Rodica Bălaşa, Nicoleta Ştirbu, Smaranda Maier, Sebastian Andone, Zoltan Bajko, Laura Bărcuţean, Septimiu Voidăzan, Anca Moţăţăianu

    Published 2020-01-01
    “…To determine the prevalence of suicidal concerns (SC) in a large multiple sclerosis (MS) patient group and to assess the major determinants that are implicated in their occurrence. …”
    Get full text
    Article
  5. 105
  6. 106

    Neuroendocrine Cell Carcinoma of Unknown Primary Arising in Long Standing History of Multiple Sclerosis by Stergios Boussios, Vasiliki Kostadima, Anna Batistatou, Ioannis Tourkantonis, George Fotopoulos, Maria I. Argyropoulou, Nicholas Pavlidis

    Published 2015-01-01
    “…Multiple sclerosis (MS) is a chronic autoimmune disease that targets myelinated axons in the central nervous system (CNS). …”
    Get full text
    Article
  7. 107
  8. 108

    Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis by Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales

    Published 2022-10-01
    “…<p><strong>Background:</strong> multiple sclerosis modifying drugs are intended to reduce the frequency of relapses, delay the progression of disability, as well as the appearance of new lesions in the Central Nervous System.…”
    Get full text
    Article
  9. 109
  10. 110

    Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis by Éric Toussirot, Matthieu Béreau, Marie Bossert, Imad Malkoun, Anne Lohse

    Published 2014-01-01
    “…Interferon beta (IFN-β) is the first line therapy of relapsing-remitting multiple sclerosis. IFN-β is a cytokine that can contribute to the development of systemic autoimmune disease including psoriasis. …”
    Get full text
    Article
  11. 111

    Bilateral Anterior and Intermediate Uveitis with Occlusive Vasculitis as Sole Manifestation of Relapse in Multiple Sclerosis by Angelica Pedraza-Concha, Karin Brandauer, Alejandro Tello, Carlos Mario Rangel, Christian Scheib

    Published 2019-01-01
    “…Diagnosis of bilateral anterior and intermediate uveitis with occlusive vasculitis attributed to a new relapse episode of multiple sclerosis was made, as the association between multiple sclerosis and intermediate uveitis is known, though the causal association is still questioned. …”
    Get full text
    Article
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119

    New optical coherence tomography biomarker for diagnosis of acute optic neuritis in multiple sclerosis by Hend Mohammed Safwat, Sanaa Ahmed Mohamed, Ahmed Hassan Elsheshiny

    Published 2025-02-01
    “…Objectives: Is imaging of retrolaminar optic nerve, during attack of acute optic neuritis in multiple sclerosis valuable? Methods: This is a prospective observational Case series study. …”
    Get full text
    Article
  20. 120